Indy Standard

U.S. Senator Todd Young (R-Ind.) issued a statement today following the U.S. Department of Commerce’s Economic Development Administration announcement that Indiana-based Heartland BioWorks, led by the Applied Research Institute, will receive approximately $51 million authorized by the CHIPS and Science Act.

“When I worked to enact the CHIPS and Science Act two years ago, I knew Indiana was well-positioned to seize on the law’s historic opportunities to lead our country on technology areas important to global competitiveness. That potential continues to become a reality for Hoosiers. Today Heartland BioWorks was one of only 12 Tech Hubs across the country to receive a funding award. From leveraging existing resources and expertise in Indiana on life sciences and manufacturing to constructing a new headquarters for workforce training to helping early stage innovative companies bridge the ‘valley of death’, Heartland BioWorks is going to solidify Indiana’s place on the global map as the preeminent location for biotech innovation and manufacturing,” said Senator Young.

Senator Young introduced the Tech Hub concept in the Endless Frontier Act of 2020, which eventually became law as a key pillar in the CHIPS and Science Act, signed into law in 2022. In October 2023, Heartland BioWorks was selected as one of 31 Tech Hubs across the country that could apply for implementation funding in Phase 2. The consortium is one of only 12 to receive funding.

Heartland BioWorks aims to transform Central Indiana into a global leader in biotechnology and biomanufacturing by increasing the region’s capacity to make and deploy life-saving medicines. Leveraging the region’s research institutions, venture ecosystem, logistics infrastructure, and established pharmaceutical and biotechnology manufacturing presence, this Tech Hub will catalyze regional biotech innovation. Heartland BioWorks seeks to strengthen the nation’s biotechnology supply chain and facilitate the rapid discovery, development, commercialization, and deployment of next-generation bioproducts in human, animal, and plant biosciences.